Acute exacerbation of chronic obstructive pulmonary disease

British Columbia Medical Journal

Volumn 50, Issue 3, 2008, Pages 138-142

  Lawati, Nabil Al ^a   FitzGerald, J Mark ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 44349095049     PISSN: 00070556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Mannino DM, Ford ES, Redd SC. Obstructive and restrictive lung disease and markers of inflammation: Data from the Third National Health and Nutrition Examination. Am J Med 2003;114:758-762.
2. O'Donnell DE, Aaron S, Bourbeau J, et al. State of the Art Compendium: Canadian Thoracic Society recommendations for the management of chronic obstructive pulmonary disease, Can Respir J 2004; 11(suppl B):7B-59B.
3. Burrows B, Earle RH. Course and prognosis of chronic obstructive lung disease: A prospective study of 200 patients. N Engl J Med 1969;280:397-404.
4. FitzGerald JM, Haddon J, Bradley-Kennedy C, et al. Resource use study in COPD (RUSlC): A prospective study to quantify the effects of COPD exacerbations on health care resource use among COPD patients. Can Resp J 2007;14:145-152.
5. FitzGerald JM, Mittmann N, Kuramoto L, et al. Economic burden of moderate and severe COPD exacerbations in Canada [abstract]. Am J Respir Crit Care Med 2007;175:A135.
6. Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1418-1422.
7. 1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: Results from the lung health study. Am J Respir Crit Care Med 2001;164:358-364.
8. Mushlin Al, Black ER, Connolly CA, et al. The necessary length of hospital stay for chronic pulmonary disease. JAMA 1991; 266:80-83.
9. Connors AF Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med 1996; 154:959-967
10. Burk RH, George RB. Acute respiratory failure in chronic obstructive pulmonary disease. Immediate and long-term prognosis. Arch Intern Med 1973;132:865-868.
11. Portier F, Defouilloy C, Muir JF. Determinants of immediate survival among chronic respiratory insufficiency patients admitted to an intensive care unit for acute respiratory failure. A prospective multicenter study. The French Task Group for Acute Respiratory Failure in Chronic Respiratory Insufficiency. Chest 1992; 101:204-210.
12. Seneff MG, Wagner DR Wagner RP et al. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. JAMA 1995;274: 1852-1857
13. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med 2000;343: 269-280.
14. Sapey E, Stockley RA. COPD exacerbations. 2: Aetiology. Thorax 2006;61:250-258.
15. Miravitlles M, GuerreroT Mayordomo C, et al. Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: A multiple logistic regression analysis. The EOLO Study Group. Respiration 2000;67:495-501.
16. Rascon-Aguilar lE, Pamer M, Wludyka P, et al. Role of gastroesophageal reflux symptoms in exacerbations of COPD. Chest 2006;130:1096-1101.
17. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. GOLD executive summary. Am J Respir Crit Care Med 2007;176:532-555.
18. Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987;106:196-204.
19. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-946.
20. Scott S, Walker P, Calverley PMA. COPD exacerbations. 4: Prevention. Thorax 2006;61:440-447
21. Turner MO, Patel A, Ginsburg S, et al. Bronchodilator delivery in acute airflow obstruction. A meta-analysis. Arch Intern Med 1997;157:1736-1744.
22. Aaron SD, Vandemheen KL, Hebert P et al. Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. N Engl J Med 2003; 348:2618-2625.
23. Wood-Baker RR, Gibson PG, Hannay M, et al. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database SystRe2005;(1):CD001288.
24. Ram FS, Rodriguez-Roisin R, Granados-Navarrete A, et al. Antibiotics for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006; (2):CD004403.
25. Puhan MA, Vollenweider D, LatshangT et al. Exacerbations of chronic obstructive pulmonary disease: When are antibiotics indicated? A systematic review. Respir Res 2007;8:30.
26. Baiter MS, La Forge J, Low DE, et al; Canadian Thoracic Society; Canadian Infectious Disease Society. Canadian guidelines for the management of acute exacerbations of chronic bronchitis. Can Respir J 2003;10(suppl B):3B-32B.
27. Rodriguez-Roisin R. COPD exacerbations. 5: Management.Thorax2006;61:535- 544.
28. Gunen H, Hacievliyagil SS, Kosar F, et al. Factors affecting survival of hospitalised patients with COPD. Eur Respir J 2005; 26:234-241.
29. Breen D, Churches T Hawker F, et al. Acute respiratory failure secondary to chronic obstructive pulmonary disease treated in the intensive care unit: A long term follow up study. Thorax 2002;57: 29-33.